Retractable Technologies (NYSE:RVP) Coverage Initiated at StockNews.com

Analysts at StockNews.com assumed coverage on shares of Retractable Technologies (NYSE:RVP) in a report released on Wednesday. The brokerage set a “hold” rating on the stock.

Retractable Technologies Stock Performance

RVP opened at $0.62 on Wednesday. Retractable Technologies has a 1 year low of $0.56 and a 1 year high of $1.34. The stock has a market cap of $18.41 million, a PE ratio of -1.14 and a beta of 2.06. The company has a current ratio of 8.57, a quick ratio of 5.92 and a debt-to-equity ratio of 0.01. The stock’s 50 day simple moving average is $0.71 and its 200-day simple moving average is $0.93.

Insider Buying and Selling at Retractable Technologies

In other Retractable Technologies news, CEO Thomas J. Shaw acquired 71,422 shares of Retractable Technologies stock in a transaction on Friday, September 20th. The shares were bought at an average price of $0.82 per share, with a total value of $58,566.04. Following the completion of the purchase, the chief executive officer now owns 14,743,907 shares in the company, valued at $12,090,003.74. This trade represents a 0.49 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Over the last ninety days, insiders have purchased 179,515 shares of company stock valued at $143,037. 55.00% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Retractable Technologies

A hedge fund recently bought a new stake in Retractable Technologies stock. PFG Investments LLC bought a new stake in shares of Retractable Technologies, Inc. (NYSE:RVP) during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned 0.12% of Retractable Technologies at the end of the most recent quarter. 7.58% of the stock is currently owned by hedge funds and other institutional investors.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.